Mangoceuticals, Inc. MGRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 68.80K | 67.90K | 94.40K | 84.20K | 168.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 68.80K | 67.90K | 94.40K | 84.20K | 168.10K |
| Cost of Revenue | 24.50K | 38.90K | 46.90K | 33.30K | 78.20K |
| Gross Profit | 44.20K | 29.00K | 47.50K | 50.90K | 89.90K |
| SG&A Expenses | 1.08M | 3.14M | 412.30K | 7.56M | 5.25M |
| Depreciation & Amortization | -- | -- | 1.12M | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.10M | 3.18M | 1.58M | 7.59M | 5.33M |
| Operating Income | -1.03M | -3.11M | -1.49M | -7.51M | -5.16M |
| Income Before Tax | -1.31M | -3.40M | -2.77M | -7.62M | -5.42M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.31M | -3.40M | -2.77M | -7.62M | -5.42M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 300.00 | 0.00 | -200.00 | 600.00 | 0.00 |
| Net Income | -1.31M | -3.40M | -2.77M | -7.62M | -5.42M |
| EBIT | -1.03M | -3.11M | -1.49M | -7.51M | -5.16M |
| EBITDA | -738.20K | -2.82M | -1.04M | -7.48M | -4.33M |
| EPS Basic | -0.09 | -0.22 | -0.22 | -0.69 | -0.57 |
| Normalized Basic EPS | -0.05 | -0.13 | -0.07 | -0.41 | -0.33 |
| EPS Diluted | -0.09 | -0.22 | -0.22 | -0.69 | -0.57 |
| Normalized Diluted EPS | -0.05 | -0.13 | -0.07 | -0.41 | -0.33 |
| Average Basic Shares Outstanding | 17.12M | 16.48M | 14.19M | 11.52M | 9.98M |
| Average Diluted Shares Outstanding | 17.12M | 16.48M | 14.19M | 11.52M | 9.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |